SEGLUROMET 7.5 mg/1

Segluromet 7.5 mg/1 combines ertugliflozin and metformin hydrochloride for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Segluromet 7.5 mg/1 is used to help manage type 2 diabetes in adults. It works by combining two active ingredients, ertugliflozin and metformin hydrochloride, to improve blood sugar levels. This medication is typically prescribed alongside diet and exercise to support overall diabetes management. People often ask, 'What is Segluromet used for?' and the answer is that it is designed to assist in controlling high blood sugar levels associated with type 2 diabetes.

Common effects of Segluromet 7.5 mg/1 may include symptoms like nausea, diarrhea, or urinary tract infections. Some individuals might experience dizziness or low blood sugar levels. These effects can vary from person to person and are not experienced by everyone who takes the medication.

Segluromet 7.5 mg/1 should be handled with care. It is important to follow the advice of a healthcare provider regarding its use, especially for those with kidney problems or a history of pancreatitis. Regular monitoring of blood sugar levels is recommended. Always store the medication as directed and keep it out of reach of children.

Segluromet 7.5 mg/1 may interact with certain medications, including diuretics, insulin, and other diabetes drugs. Alcohol consumption should be avoided as it can increase the risk of low blood sugar. It is important to inform a healthcare provider about all medications being taken to avoid potential interactions.